Safety, quality and reliability

Product quality and safety are kept with the highest priorisation. This applies for our own products but also for those that are imported from the European countries. Regular audits and inspections by the local governmental health authorities as well as strict internal controls and quality management ensure the highest level of safety. Every product release is preceded by a flawless documention. 

HAEMATO complies with the EU Good Manufacturing Practice (GMP) and the norms of the German Pharmaceutical Law (AMG). Throughout the entire value chain HAEMATO has established a quality management system that guarantees the compliance with the European GMP guidelines.


Die HAEMATO AG ist ein börsennotiertes pharmazeutisches Unternehmen mit Fo-kus auf die Wachstumsmärkte patentfreier und patentgeschützter Arzneimittel...


IFRS-Ergebnis Q1 2017, Umsatz 67,9 Mio. Euro (Vorjahresperiode: 67,9 Mio. Euro), EBIT 2,8 Mio. Euro (Vorjahresperiode: 3,5 Mio. Euro)...


2016: Vorläufiges IFRS-Ergebnis, Umsatzwachstum 20% auf 275,6 Mio. Euro, EBIT-Wachstum (operatives Ergebnis) 63% auf 13,4 Mio. Euro;...

Order service - Telephone: +49 30 677 98 67 60
Aktuelle News